SSRIs and Supplements: What Is Safe to Combine

Do not combine an SSRI with St. John's wort, 5-HTP or tryptophan unless your prescriber agrees: MedlinePlus lists St. John's wort and tryptophan as possible interactions with sertraline¹. Ashwagandha, magnesium and L-theanine have no documented interaction with Zoloft or other SSRIs, and melatonin has none except with fluvoxamine, which raised blood levels of a melatonin dose about 17-fold in a small study².

The evidence for ashwagandha, magnesium and L-theanine is thin. Only a few small trials, each lasting 6 to 8 weeks, have added one of them to antidepressant treatment^{3, 4, 5}. "No known interaction" here means none has been found so far, not that the combination was proven safe. The rest of this guide sorts each supplement by what the evidence does and does not show, and names the signs that mean a combination is going wrong.

Three groups matter, sorted by what to do. Avoid the first group unless a prescriber supervises, check with your prescriber before using the second, and expect no documented interaction from the third.

Avoid unless a prescriber supervises

• St. John's wort: a review of drug interactions found it caused serotonin syndrome when given with SSRIs such as sertraline and paroxetine⁶.
• Tryptophan: MedlinePlus names it as a product that may interact with sertraline¹, and a review describes rare serotonin syndrome when it is combined with serotonergic drugs⁷.
• 5-HTP: it is the immediate precursor in the body's serotonin production⁸, so it adds to what an SSRI is already doing.

Use caution and tell your prescriber

• Aspirin and NSAIDs: MedlinePlus lists them as possible interactions with sertraline¹.
• SAMe: NIH's NCCIH says it might interact with antidepressants and other products that raise serotonin⁹.
• Ashwagandha: drowsiness and liver injury are the documented concerns, not a serotonin effect.
• Ginkgo, if you also take a blood thinner: NCCIH says it may increase the risk of bleeding in people taking anticoagulants such as warfarin¹⁰.

No documented SSRI interaction

Melatonin (except with fluvoxamine), magnesium and L-theanine fall here. Each section below says what was and was not studied.

Three mechanisms cover nearly every real concern: too much serotonin, extra bleeding risk, and changes in how the liver clears a drug.

Serotonin syndrome

Serotonin syndrome is caused by overstimulation of serotonin receptors by serotonergic drugs. It can occur from one drug or from an interaction between two or more serotonergic drugs¹¹. Its core features are neuromuscular excitation, autonomic dysfunction and altered mental status in someone starting or changing serotonergic therapy¹¹. The Zoloft label names tryptophan and St. John's wort among the products that raise this risk, along with prescription drugs such as triptans, tramadol, lithium and amphetamines¹².

Mild cases often need the serotonergic agent reduced or stopped, while severe cases with hyperthermia and rigidity need intensive supportive care¹³.

Bleeding

SSRIs affect platelets. A meta-analysis of 42 observational studies linked SSRI use to a higher risk of severe bleeding (odds ratio 1.41, 95% CI 1.27-1.57)¹⁴. Anything else that thins the blood adds to that baseline.

Liver enzymes

St. John's wort activates the pregnane X receptor and induces the enzyme CYP3A4 and the transporter P-glycoprotein, and the effect rises with the hyperforin content of the product¹⁵. That is why it also weakens many unrelated medicines¹⁶.

Avoid St. John's wort. The National Center for Complementary and Integrative Health says it has been clearly shown to interact in dangerous, sometimes life-threatening ways with a variety of medicines, and that taking it with certain antidepressants may increase serotonin-related side effects, which can be serious¹⁶.

A systematic review of herb-drug interactions counted 41 case reports or case series and 17 clinical trials. It found that St. John's wort caused mild serotonin syndrome with sertraline, paroxetine and nefazodone¹⁷. A family-medicine review advises most patients on any pharmacologic therapy to avoid St. John's wort and goldenseal¹⁸.

The same review rates black cohosh, cranberry, ginkgo, milk thistle, American ginseng, saw palmetto and valerian as low likelihood for drug interactions, with caveats. Curcumin, echinacea, garlic, Asian ginseng, green tea extract and kava may interact with a few medicines but are likely safe with others¹⁸. That review does not single out SSRIs, so it is a general guide, not an SSRI clearance.

If you take St. John's wort now and want to stop, ask your prescriber how. Do not stop your SSRI on your own: MedlinePlus warns that stopping sertraline suddenly can cause withdrawal symptoms¹.

Depression itself is covered on our depression page, and our St. John's wort for depression page reviews the trials for the herb on its own.

No interaction has been documented, but the evidence is one small trial. In 30 people with obsessive-compulsive disorder who were already taking SSRIs, adding ashwagandha root extract (120 mg a day) for 6 weeks improved symptoms more than placebo, and no adverse events were reported³. The trial was small and short and was not designed to measure an interaction, so it cannot rule one out.

The NIH Office of Dietary Supplements says ashwagandha might interact with thyroid, diabetes and blood pressure medications, sedatives and immune-suppressing drugs, and it does not list antidepressants¹⁹. That is an absence of evidence, not proof of safety.

Two documented problems are worth knowing regardless of the SSRI. Drowsiness is one of the common side effects of ashwagandha¹⁹, and MedlinePlus says sertraline may make you drowsy¹. Liver injury is the other: a case series of 5 patients described jaundice 2-12 weeks after starting an ashwagandha supplement, and liver tests normalized within 1-5 months in four of them²⁰.

The same NIH fact sheet says studies found no safety concerns for up to about 3 months of use, that ashwagandha may affect how the thyroid gland works, and that it may not be safe for people with prostate cancer or those who are pregnant or breastfeeding¹⁹.

Does ashwagandha affect antidepressants?

We found no study measuring ashwagandha's effect on antidepressant blood levels. A meta-analysis of 9 randomized trials in 558 patients found lower stress and anxiety scores than placebo, and 4 trials reported mild to moderate adverse events²¹. None of the trials in that review were SSRI interaction studies.

Does ashwagandha mess with serotonin levels?

We found no human study of ashwagandha and serotonin levels, and the NIH fact sheet does not describe a serotonin effect¹⁹. A serotonin-related interaction is therefore unproven, not ruled out.

If you want to try it, a reasonable approach is to tell your prescriber first, add only ashwagandha, and watch for new drowsiness or yellowing of the skin or eyes. Our ashwagandha for anxiety page covers what it does for anxiety, and the ashwagandha page covers dose and safety.

For sertraline, escitalopram and fluoxetine we found no reported interaction with melatonin. Fluvoxamine is the exception.

In 5 healthy men, taking 50 mg of fluvoxamine with a 5 mg melatonin dose made total melatonin exposure about 17-fold higher and peak levels about 12-fold higher. The authors concluded that fluvoxamine slows how the body clears melatonin². In an earlier study of healthy volunteers, early-morning melatonin levels rose significantly after fluvoxamine but not after four other antidepressants, none of them an SSRI (groups of 4 to 7 people, which is small)²². A systematic review of melatonin pharmacokinetics also lists fluvoxamine among the factors that change how the body handles melatonin²³.

Melatonin is cleared mainly through the liver enzyme CYP1A2²⁴, and only a potent CYP1A2 inhibitor impaired its breakdown at realistic concentrations in a laboratory screen of common drugs²⁴. Oral melatonin has a bioavailability of about 15% and a half-life of about 45 minutes, but peak blood levels varied widely between studies²³. If you take fluvoxamine, ask your prescriber before your first dose of melatonin. With the other SSRIs no interaction has been reported, but we found no study of the combination, so start with a low dose.

See our melatonin page and melatonin for insomnia page for dosing and the sleep evidence.

No interaction between either supplement and an SSRI has been reported in the sources we read, and MedlinePlus does not list them among the products that may interact with sertraline¹. Each has been added to antidepressant treatment in one small trial, described below, so the same caveat applies.

Magnesium

A meta-analysis of 7 randomized trials in 325 adults with depression found that magnesium supplements lowered depression scores versus placebo (standardized mean difference -0.919, 95% CI -1.443 to -0.396)²⁵. The authors called for larger trials.

One double-blind trial gave 37 adults with recurrent depression fluoxetine (Prozac) plus magnesium (120 mg a day) or placebo for 8 weeks, with monitoring for clinical abnormalities and measurement of fluoxetine blood levels. Depression scores did not differ between the groups, and the abstract reports no interaction⁴. For form and timing, see when to take magnesium and our magnesium page.

L-theanine

A systematic review of 31 randomized trials in 1,168 people found no serious adverse events²⁶. A single 200 mg dose improved choice reaction time, but the stress effect was modest and largely driven by studies at high risk of bias²⁶.

In one 8-week trial, 46 people with generalized anxiety took L-theanine (450 to 900 mg) or placebo alongside their usual antidepressant. L-theanine did not ease anxiety more than placebo, and the abstract does not name the antidepressants or report side effects⁵. See L-theanine and L-theanine for anxiety.

Avoid 5-HTP and tryptophan unless a prescriber supervises⁷. Ask before using SAMe: NIH's NCCIH says it might interact with antidepressants and other products that raise serotonin⁹.

5-HTP and tryptophan

Tryptophan taken with serotonin-enhancing drugs, including antidepressants, can cause tremor, nausea and dizziness at higher doses, and rarely serotonin syndrome with delirium, myoclonus, hyperthermia and coma⁷. Fernstrom's review notes that the evidence is small and largely anecdotal⁷. A review of 5-HTP found no definitive cases of toxicity in 20 years of worldwide use⁸, but that concerns contaminants, not mixing with an SSRI. We found no controlled trial of 5-HTP with an SSRI, so the caution rests on the shared serotonin pathway. Our 5-HTP page and tryptophan page have the details.

SAMe

An updated meta-analysis of 14 trials in 1,522 people found no significant difference between SAMe and placebo, whether SAMe was taken alone or added to another antidepressant, and no significant difference between SAMe and imipramine or escitalopram. Doses ranged from 200 to 3,200 mg a day²⁷. The authors said SAMe may relieve depression about as well as those two drugs, but urged caution because the studies were few, and advised patients to talk to a doctor first²⁷.

NCCIH adds two safety points. SAMe might interact with antidepressants, L-tryptophan and St. John's wort, which all raise serotonin, and people with bipolar disorder should take it only under a health care provider's supervision because it may worsen mania⁹. Read more on our SAMe for depression symptoms page.

NSAIDs have the strongest evidence of adding to SSRI bleeding risk. A network meta-analysis of 15 studies in 82,605 patients found more GI bleeds with an SSRI plus an NSAID than with an SSRI alone (odds ratio 2.14, 95% CI 1.52-3.02)²⁸. It also found more bleeds than with an NSAID alone (odds ratio 1.49)²⁸.

If you also take blood thinners, a meta-analysis of 32 non-randomized studies found that people on anticoagulants who also took a serotonin reuptake inhibitor, the antidepressant class that includes SSRIs, had higher odds of major bleeding (odds ratio 1.39). The odds were also higher for those on antiplatelet drugs (odds ratio 1.45), a result based on only 2 studies²⁹.

Omega-3 and ginkgo

Neither of these two supplements was tested with SSRIs, and the trial evidence for them differs:

• Omega-3: a meta-analysis of 11 randomized trials in 120,643 patients found no overall increase in bleeding (rate ratio 1.09, 95% CI 0.91-1.31). High-dose purified EPA raised relative risk by 50% but absolute risk by only 0.6%³⁰.
• Ginkgo: a meta-analysis of 18 randomized trials in 1,985 adults found no clinically relevant effect on blood clotting tests³¹, but those were lab measures, not bleeding events. NIH's NCCIH says ginkgo may increase the risk of bleeding in people taking anticoagulants such as warfarin¹⁰, and a systematic review of herb-drug interactions lists bleeding when ginkgo was combined with warfarin¹⁷.

If you take an SSRI together with aspirin or a blood thinner, ask your prescriber before adding ginkgo or omega-3¹⁰. See our omega-3 and ginkgo pages.

Call your doctor right away if you notice agitation, hallucinations, fever, sweating, confusion, a fast heartbeat, shivering, severe muscle stiffness or twitching, loss of coordination, nausea, vomiting or diarrhea. MedlinePlus lists exactly these as serious symptoms to report¹.

The pattern to watch is new symptoms soon after you start a supplement or raise a dose. Diagnosis is by clinical assessment, because no laboratory test confirms it¹³. Mild cases can look like a stomach bug or anxiety, which is why timing is the clue.

Severe symptoms such as high fever, rigidity or seizures are an emergency. Call emergency services.

Use this decision rule:

1. Write down everything you take, including doses. MedlinePlus advises keeping a written list of medicines, vitamins, minerals and supplements and carrying it to appointments¹.
2. Ask a pharmacist or prescriber about the specific product. Most patients do not tell clinicians about supplement use, and that is the main way interactions are missed¹⁸.
3. Add one supplement at a time, so a new symptom has one possible cause.
4. Skip the serotonin-raising group: St. John's wort, 5-HTP and tryptophan, unless a prescriber supervises^{16, 7}.
5. Do not change your SSRI dose yourself. Stopping suddenly can cause withdrawal symptoms¹.

Supplements in this guide

• St. Johns Wort
• 5-HTP
• Ashwagandha
• Melatonin
• Magnesium
• L-Theanine

We searched PubMed for serotonin syndrome, St. John's wort, herb-drug interactions, melatonin pharmacokinetics, SSRI bleeding, and each supplement named above. We also read NIH NCCIH, NIH Office of Dietary Supplements and MedlinePlus pages and the Zoloft prescribing label on DailyMed. We prioritized systematic reviews, meta-analyses and authoritative fact sheets.

The main limit: only a few small, short trials have combined an antidepressant with ashwagandha, magnesium or L-theanine, and for melatonin the clearest data cover fluvoxamine alone. Where we say "no documented interaction," that is what it means. Last checked October 14, 2026. This is not medical advice; ask your pharmacist or prescriber about your own regimen.

1. MedlinePlus. Sertraline: Drug Information. National Library of Medicine. https://medlineplus.gov/druginfo/meds/a697048.html
2. Härtter S, et al. Increased bioavailability of oral melatonin after fluvoxamine coadministration. Clin Pharmacol Ther. 2000;67(1):1-6. doi:10.1067/mcp.2000.104071
3. Jahanbakhsh SP, et al. Evaluation of the efficacy of Withania somnifera (Ashwagandha) root extract in patients with obsessive-compulsive disorder: A randomized double-blind placebo-controlled trial. Complement Ther Med. 2016;27:25-9. doi:10.1016/j.ctim.2016.03.018
4. Ryszewska-Pokraśniewicz B, et al. Effects of Magnesium Supplementation on Unipolar Depression: A Placebo-Controlled Study and Review of the Importance of Dosing and Magnesium Status in the Therapeutic Response. Nutrients. 2018;10(8). doi:10.3390/nu10081014
5. Sarris J, et al. L-theanine in the adjunctive treatment of generalized anxiety disorder: A double-blind, randomised, placebo-controlled trial. J Psychiatr Res. 2019;110:31-37. doi:10.1016/j.jpsychires.2018.12.014
6. Zhou S, et al. Pharmacokinetic interactions of drugs with St John's wort. J Psychopharmacol. 2004;18(2):262-76. doi:10.1177/0269881104042632
7. Fernstrom JD. Effects and side effects associated with the non-nutritional use of tryptophan by humans. J Nutr. 2012;142(12):2236S-2244S. doi:10.3945/jn.111.157065
8. Das YT, et al. Safety of 5-hydroxy-L-tryptophan. Toxicol Lett. 2004;150(1):111-22. doi:10.1016/j.toxlet.2003.12.070
9. National Center for Complementary and Integrative Health. S-Adenosyl-L-Methionine (SAMe): In Depth. https://www.nccih.nih.gov/health/sadenosyllmethionine-same-in-depth
10. National Center for Complementary and Integrative Health. Ginkgo: Usefulness and Safety. https://www.nccih.nih.gov/health/ginkgo
11. Mikkelsen N, et al. Serotonin syndrome-A focused review. Basic Clin Pharmacol Toxicol. 2023;133(2):124-129. doi:10.1111/bcpt.13912
12. DailyMed. Zoloft (sertraline hydrochloride) tablets and oral concentrate: prescribing information. U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fda754f6-d0f3-4dce-a17a-927d64f912f7
13. Chiew AL, et al. Management of serotonin syndrome (toxicity). Br J Clin Pharmacol. 2025;91(3):654-661. doi:10.1111/bcp.16152
14. Laporte S, et al. Bleeding risk under selective serotonin reuptake inhibitor (SSRI) antidepressants: A meta-analysis of observational studies. Pharmacol Res. 2017;118:19-32. doi:10.1016/j.phrs.2016.08.017
15. Nicolussi S, et al. Clinical relevance of St. John's wort drug interactions revisited. Br J Pharmacol. 2020;177(6):1212-1226. doi:10.1111/bph.14936 Our study summary.
16. National Center for Complementary and Integrative Health. St. John's Wort: Usefulness and Safety. https://www.nccih.nih.gov/health/st-johns-wort
17. Izzo AA, et al. Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs. 2001;61(15):2163-75. doi:10.2165/00003495-200161150-00002
18. Asher GN, et al. Common Herbal Dietary Supplement-Drug Interactions. Am Fam Physician. 2017;96(2):101-107. https://pubmed.ncbi.nlm.nih.gov/28762712/
19. National Institutes of Health, Office of Dietary Supplements. Ashwagandha: Is it helpful for stress, anxiety, or sleep? Fact Sheet for Consumers. https://ods.od.nih.gov/factsheets/Ashwagandha-Consumer/
20. Björnsson HK, et al. Ashwagandha-induced liver injury: A case series from Iceland and the US Drug-Induced Liver Injury Network. Liver Int. 2020;40(4):825-829. doi:10.1111/liv.14393
21. Arumugam V, et al. Effects of Ashwagandha (Withania Somnifera) on stress and anxiety: A systematic review and meta-analysis. Explore (NY). 2024;20(6):103062. doi:10.1016/j.explore.2024.103062 Our study summary.
22. Demisch K, et al. The influence of acute and subchronic administration of various antidepressants on early morning melatonin plasma levels in healthy subjects: increases following fluvoxamine. J Neural Transm. 1987;68(3-4):257-70. doi:10.1007/BF02098502
23. Harpsøe NG, et al. Clinical pharmacokinetics of melatonin: a systematic review. Eur J Clin Pharmacol. 2015;71(8):901-9. doi:10.1007/s00228-015-1873-4
24. Papagiannidou E, et al. Potential drug interactions with melatonin. Physiol Behav. 2014;131:17-24. doi:10.1016/j.physbeh.2014.04.016
25. Moabedi M, et al. Magnesium supplementation beneficially affects depression in adults with depressive disorder: a systematic review and meta-analysis of randomized clinical trials. Front Psychiatry. 2023;14:1333261. doi:10.3389/fpsyt.2023.1333261
26. Gerolymos C, et al. Cognitive and affective effects of L-Theanine: a systematic review and meta-analysis of 31 randomized trials. Mol Psychiatry. 2026. doi:10.1038/s41380-026-03727-9
27. Peng TR, et al. S-Adenosylmethionine (SAMe) as an adjuvant therapy for patients with depression: An updated systematic review and meta-analysis. Gen Hosp Psychiatry. 2024;86:118-126. doi:10.1016/j.genhosppsych.2024.01.001
28. Haghbin H, et al. Risk of Gastrointestinal Bleeding with Concurrent Use of NSAID and SSRI: A Systematic Review and Network Meta-Analysis. Dig Dis Sci. 2023;68(5):1975-1982. doi:10.1007/s10620-022-07788-y
29. Nochaiwong S, et al. Use of serotonin reuptake inhibitor antidepressants and the risk of bleeding complications in patients on anticoagulant or antiplatelet agents: a systematic review and meta-analysis. Ann Med. 2022;54(1):80-97. doi:10.1080/07853890.2021.2017474
30. Javaid M, et al. Bleeding Risk in Patients Receiving Omega-3 Polyunsaturated Fatty Acids: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. J Am Heart Assoc. 2024;13(10):e032390. doi:10.1161/JAHA.123.032390
31. Kellermann AJ, et al. Is there a risk of bleeding associated with standardized Ginkgo biloba extract therapy? A systematic review and meta-analysis. Pharmacotherapy. 2011;31(5):490-502. doi:10.1592/phco.31.5.490 Our study summary.